Search | IOVS | ARVO Journals

Showing 1 – 20 of 29

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Transcriptome analysis of the pathophysiological significance of adrenomedullin 2 in the mouse choroidal neovascularization model

Shinji Kakihara; Takayuki Sakurai; Akiko Kamiyoshi; Megumu Tanaka; Hisaka Kawate; Yuka Ichikawa-Shindo; Yunlu Zhao; Yorishige Matsuda; Kazutaka Hirabayashi; Akira Imai; Yasuhiro Iesato; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3875 – A0077. doi:

ARVO Annual Meeting Abstract June 2022

Investigation of the therapeutic effect of adrenomedullin on experimental autoimmune uveitis

Yorishige Matsuda; Shinji Kakihara; Kazutaka Hirabayashi; Akira Imai; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Megumu Tanaka; Hisaka Kawate; Yunlu Zhao; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3571 – A0458. doi:

ARVO Annual Meeting Abstract June 2021

Pathophysiological roles of adrenomedullin-2 in mouse model of ocular neovascularization

Shinji Kakihara; Masaaki Tanaka; Kazutaka Hirabayashi; Akira Imai; Yuichi Toriyama; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Hisaka Kawate; Yuka Ichikawa-Shindo; Megumu Tanaka; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2946. doi:

ARVO Annual Meeting Abstract June 2021

Changes in retinal sensitivity, thickness, and perfusion density following treatment for branch retinal vein occlusion (BRVO)

Kazutaka Hirabayashi; Srinivas R Sadda; Akira Imai; Yasuhiro Iesato; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3177. doi:

ARVO Annual Meeting Abstract June 2021

Evaluation of the vitreoretinal interface in eyes with diabetic retinopathy using a 23 mm wide-field OCT

Takao Hirano; Yoshiaki Chiku; Ken Hoshiyama; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1912. doi:

ARVO Annual Meeting Abstract June 2020

Comparison of ranibizumab with or without focal/grid laser for macular edema secondary to branch retinal vein occlusion: 12-month results from the ZIPANGU study

Toshinori Murata; Mineo Kondo; Makoto Inoue; Shintaro Nakao; Rie Osaka; Chieko Shiragami; Kenji Sogawa; Akikazu Mochizuki; Rumiko Shiraga; Yohei Ohashi; Takeumi Kaneko; Akitaka Tsujikawa; Motohiro Kamei

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3522. doi:

ARVO Annual Meeting Abstract June 2020

The therapeutic potency of exogenous administration of adrenomedullin-2 in ocular neovascular diseases

Shinji Kakihara; Masaaki Tanaka; Kazutaka Hirabayashi; Akira Imai; Yuichi Toriyama; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Hisaka Kawate; Yuka Ichikawa-Shindo; Megumu Tanaka; Kun Dai; Nanqi Cui; Yangxuan Wei; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4937. doi:

ARVO Annual Meeting Abstract June 2020

Evaluation of wide-field OCT angiography using Xephilio OCT-S1 for detecting retinal neovascularization in eyes with proliferative diabetic retinopathy

Takao Hirano; Ken Hoshiyama; Yuichi Toriyama; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5300. doi:

ARVO Annual Meeting Abstract July 2019

Change of baseline visual acuity in eyes with age-related macular degeneration from 2006-201 5

Tomoko Sawada; Tsutomu Yasukawa; Hiroko Imaizumi; Hisashi Mastubara; Kazuhiro Kimura; Hiroto Terasaki; Hiroto Ishikawa; Tomoya Murakami; Masaru Takeuchi; Yoshinori Mitamura; Mariko Yamashita; Yoshihiro Takamura; Toshinori Murata; Jiro Kogo; Taiji Sakamoto; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1160. doi:

ARVO Annual Meeting Abstract July 2019

One year follow-up data on changes in aqueous VEGF levels in eyes with diabetic macula edema treated with ranibizumab using the pro re nata regimen

Takao Hirano; Yuichi Toriyama; Kazutaka Hirabayashi; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3660. doi:

ARVO Annual Meeting Abstract July 2019

Correlation between initial visit binocular intraocular pressure difference and mean pulse pressure, and the number of ranibizumab administrations in branch retinal vein occlusion

Kazutaka Hirabayashi; Akira Imai; Yasuhiro Iesato; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4069. doi:

ARVO Annual Meeting Abstract July 2019

Pathophysiological significance of adrenomedullin-RAMP2 system in age-related macular degeneration

Masaaki Tanaka; Kazutaka Hirabayashi; Akira Imai; Yuichi Toriyama; Yasuhiro Iesato; Akihiro Yamauchi; Megumu Tanaka; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Hisaka Kawate; Toshinori Murata; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5382. doi:

ARVO Annual Meeting Abstract July 2019

Change in 1-year visual acuity gain with age-related macular degeneration from 2006 and 2015

Sachi Nishino; Tsutomu Yasukawa; Hiroko Imaizumi; Hisashi Mastubara; Hiroto Ishikawa; Kazuhiro Kimura; Hiroto Terasaki; Yoshinori Mitamura; Toshinori Murata; Mariko Yamashita; Jiro Kogo; Masaru Takeuchi; Yoshihiro Takamura; Tomoya Murakami; Taiji Sakamoto; Masahito Ohji

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):92. doi:

ARVO Annual Meeting Abstract July 2018

Investigation of the therapeutic effect of adrenomedullin on central retinal vein occlusion

Kazutaka Hirabayashi; Toshinori Murata; Yasuhiro Iesato; Akira Imai; Yuichi Toriyama; Masaaki Tanaka; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Hisaka Kawate; Megumu Tanaka; Akihiro Yamauchi; Takayuki Shindo

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4257. doi:

ARVO Annual Meeting Abstract July 2018

Identifying suspicious regions in optical coherence tomography angiography using convolutional neural networks

Conor Leahy; Thomas Perez; Mary K Durbin; Amir H Kashani; Toshinori Murata; Nathan Shemonski

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1724. doi:

ARVO Annual Meeting Abstract June 2017

Novel mouse model of CRVO induced by intraperitoneal injection of Rose Bengal with laser radiation

Kazutaka Hirabayashi; Yasuhiro Iesato; Akira Imai; Yuichi Toriyama; Sakurai Takayuki; Kamiyoshi Akiko; Yuka Ichikawa-Shindo; Hisaka Kawate; Megumu Tanaka; Akihiro Yamauchi; Toshinori Murata; Shindo Takayuki

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):3662. doi:

ARVO Annual Meeting Abstract September 2016

Changes in aqueous concentrations of various cytokines after intravitreal ranibizumab for diabetic macular edema.

Yuichi Toriyama; Takao Hirano; Motoharu Tokimitsu; Dai Chiba; Toshiyuki Kyomoto; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2072. doi:

ARVO Annual Meeting Abstract September 2016

Association of diabetic retinopathy severity with lens fluorescence ratio reflecting advanced glycation end product level

Takao Hirano; Yuichi Toriyama; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5441. doi:

ARVO Annual Meeting Abstract September 2016

One-year Outcomes following Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in Japanese Patients: The APOLLO study

Yuji Oshima; Kenichi Kimoto; Noriko Yoshida; Kimihiko Fujisawa; Shozo Sonoda; Toshiaki Kubota; Toshinori Murata; Taiji Sakamoto; Koh-Hei Sonoda; Tatsuro Ishibashi

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3693. doi:

ARVO Annual Meeting Abstract June 2015

Adrenomedullin reduces VEGF-induced retinal vascular hyperpermeability.

Akira Imai; Yuichi Toriyama; Yasuhiro Iesato; Takayuki Sakurai; Akiko Kamiyoshi; Yuka Ichikawa-Shindo; Hisaka Kawate; Takayuki Shindo; Toshinori Murata

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):2296. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Transcriptome analysis of the pathophysiological significance of adrenomedullin 2 in the mouse choroidal neovascularization model

Investigation of the therapeutic effect of adrenomedullin on experimental autoimmune uveitis

Pathophysiological roles of adrenomedullin-2 in mouse model of ocular neovascularization

Changes in retinal sensitivity, thickness, and perfusion density following treatment for branch retinal vein occlusion (BRVO)

Evaluation of the vitreoretinal interface in eyes with diabetic retinopathy using a 23 mm wide-field OCT

Comparison of ranibizumab with or without focal/grid laser for macular edema secondary to branch retinal vein occlusion: 12-month results from the ZIPANGU study

The therapeutic potency of exogenous administration of adrenomedullin-2 in ocular neovascular diseases

Evaluation of wide-field OCT angiography using Xephilio OCT-S1 for detecting retinal neovascularization in eyes with proliferative diabetic retinopathy

Change of baseline visual acuity in eyes with age-related macular degeneration from 2006-201 5

One year follow-up data on changes in aqueous VEGF levels in eyes with diabetic macula edema treated with ranibizumab using the pro re nata regimen

Correlation between initial visit binocular intraocular pressure difference and mean pulse pressure, and the number of ranibizumab administrations in branch retinal vein occlusion

Pathophysiological significance of adrenomedullin-RAMP2 system in age-related macular degeneration

Change in 1-year visual acuity gain with age-related macular degeneration from 2006 and 2015

Investigation of the therapeutic effect of adrenomedullin on central retinal vein occlusion

Identifying suspicious regions in optical coherence tomography angiography using convolutional neural networks

Novel mouse model of CRVO induced by intraperitoneal injection of Rose Bengal with laser radiation

Changes in aqueous concentrations of various cytokines after intravitreal ranibizumab for diabetic macular edema.

Association of diabetic retinopathy severity with lens fluorescence ratio reflecting advanced glycation end product level

One-year Outcomes following Intravitreal Aflibercept for Polypoidal Choroidal Vasculopathy in Japanese Patients: The APOLLO study

Adrenomedullin reduces VEGF-induced retinal vascular hyperpermeability.

To View More...

You must be signed into an individual account to use this feature.